Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

Akihiro Sugawara; Akito Sueki; Tomoyasu Hirose; Kenichiro Nagai; Hiroaki Gouda; Shuichi Hirono; Hideaki Shima; Kiyoko S. Akagawa; Satoshi Õmura; Toshiaki Sunazuka

doi:10.1016/j.bmcl.2011.04.004

Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

Akihiro Sugawara, Akito Sueki, Tomoyasu Hirose, Kenichiro Nagai, Hiroaki Gouda, Shuichi Hirono, Hideaki Shima, Kiyoko S. Akagawa, Satoshi Õmura, Toshiaki Sunazuka

Research output: Contribution to journal › Article › peer-review

41 Citations (Scopus)

Abstract

Herein, we report the design and synthesis of the novel 12-membered non-antibiotic macrolide (8R,9S)-8,9-dihydro-6,9-epoxy-8,9- anhydropseudoerythromycin A (EM900), which was found to be a potent anti-inflammatory and/or immunomodulatory agent, capable of promoting monocyte to macrophage differentiation. This molecule shows improved acid stability, does not exhibit any anti-bacterial activity and has relatively low cytotoxicity against THP-1 cells. In addition, one of its analogues, (8R,9S)-4″,13-O- diacetyl-8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM911), was found to be twice as effective as EM900.

Original language	English
Pages (from-to)	3373-3376
Number of pages	4
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	21
Issue number	11
DOIs	https://doi.org/10.1016/j.bmcl.2011.04.004
Publication status	Published - 2011 Jun 1
Externally published	Yes

Keywords

(8R,9S)-8,9-Dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM900)
14-Membered non-antibiotic macrolide
Anti-inflammatory agent
Diffuse panbronchiolitis
Immunomodulatory agent

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2011.04.004

Cite this

Sugawara, A., Sueki, A., Hirose, T., Nagai, K., Gouda, H., Hirono, S., Shima, H., Akagawa, K. S., Õmura, S., & Sunazuka, T. (2011). Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents. Bioorganic and Medicinal Chemistry Letters, 21(11), 3373-3376. https://doi.org/10.1016/j.bmcl.2011.04.004

Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents. / Sugawara, Akihiro; Sueki, Akito; Hirose, Tomoyasu; Nagai, Kenichiro; Gouda, Hiroaki; Hirono, Shuichi; Shima, Hideaki; Akagawa, Kiyoko S.; Õmura, Satoshi; Sunazuka, Toshiaki.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 21, No. 11, 01.06.2011, p. 3373-3376.

Research output: Contribution to journal › Article › peer-review

Sugawara, A, Sueki, A, Hirose, T, Nagai, K, Gouda, H, Hirono, S, Shima, H, Akagawa, KS, Õmura, S & Sunazuka, T 2011, 'Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents', Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 11, pp. 3373-3376. https://doi.org/10.1016/j.bmcl.2011.04.004

Sugawara, Akihiro ; Sueki, Akito ; Hirose, Tomoyasu ; Nagai, Kenichiro ; Gouda, Hiroaki ; Hirono, Shuichi ; Shima, Hideaki ; Akagawa, Kiyoko S. ; Õmura, Satoshi ; Sunazuka, Toshiaki. / Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents. In: Bioorganic and Medicinal Chemistry Letters. 2011 ; Vol. 21, No. 11. pp. 3373-3376.

@article{c1e1a7b607454bed90ebdabd9b3707c4,

title = "Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents",

abstract = "Herein, we report the design and synthesis of the novel 12-membered non-antibiotic macrolide (8R,9S)-8,9-dihydro-6,9-epoxy-8,9- anhydropseudoerythromycin A (EM900), which was found to be a potent anti-inflammatory and/or immunomodulatory agent, capable of promoting monocyte to macrophage differentiation. This molecule shows improved acid stability, does not exhibit any anti-bacterial activity and has relatively low cytotoxicity against THP-1 cells. In addition, one of its analogues, (8R,9S)-4″,13-O- diacetyl-8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM911), was found to be twice as effective as EM900.",

keywords = "(8R,9S)-8,9-Dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM900), 14-Membered non-antibiotic macrolide, Anti-inflammatory agent, Diffuse panbronchiolitis, Immunomodulatory agent",

author = "Akihiro Sugawara and Akito Sueki and Tomoyasu Hirose and Kenichiro Nagai and Hiroaki Gouda and Shuichi Hirono and Hideaki Shima and Akagawa, {Kiyoko S.} and Satoshi {\~O}mura and Toshiaki Sunazuka",

year = "2011",

month = jun,

day = "1",

doi = "10.1016/j.bmcl.2011.04.004",

language = "English",

volume = "21",

pages = "3373--3376",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

AU - Sugawara, Akihiro

AU - Sueki, Akito

AU - Hirose, Tomoyasu

AU - Nagai, Kenichiro

AU - Gouda, Hiroaki

AU - Hirono, Shuichi

AU - Shima, Hideaki

AU - Akagawa, Kiyoko S.

AU - Õmura, Satoshi

AU - Sunazuka, Toshiaki

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Herein, we report the design and synthesis of the novel 12-membered non-antibiotic macrolide (8R,9S)-8,9-dihydro-6,9-epoxy-8,9- anhydropseudoerythromycin A (EM900), which was found to be a potent anti-inflammatory and/or immunomodulatory agent, capable of promoting monocyte to macrophage differentiation. This molecule shows improved acid stability, does not exhibit any anti-bacterial activity and has relatively low cytotoxicity against THP-1 cells. In addition, one of its analogues, (8R,9S)-4″,13-O- diacetyl-8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM911), was found to be twice as effective as EM900.

AB - Herein, we report the design and synthesis of the novel 12-membered non-antibiotic macrolide (8R,9S)-8,9-dihydro-6,9-epoxy-8,9- anhydropseudoerythromycin A (EM900), which was found to be a potent anti-inflammatory and/or immunomodulatory agent, capable of promoting monocyte to macrophage differentiation. This molecule shows improved acid stability, does not exhibit any anti-bacterial activity and has relatively low cytotoxicity against THP-1 cells. In addition, one of its analogues, (8R,9S)-4″,13-O- diacetyl-8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM911), was found to be twice as effective as EM900.

KW - (8R,9S)-8,9-Dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM900)

KW - 14-Membered non-antibiotic macrolide

KW - Anti-inflammatory agent

KW - Diffuse panbronchiolitis

KW - Immunomodulatory agent

UR - http://www.scopus.com/inward/record.url?scp=79956084563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956084563&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2011.04.004

DO - 10.1016/j.bmcl.2011.04.004

M3 - Article

C2 - 21524580

AN - SCOPUS:79956084563

VL - 21

SP - 3373

EP - 3376

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 11

ER -

Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this